HealthcareServices

Metagenomics In Healthcare Market Dynamics 2026: Future Outlook and Key Insights

March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the metagenomics in healthcare market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Metagenomics In Healthcare Market size between 2026 and 2035?

The metagenomics in healthcare market size has seen substantial growth in recent years. It is anticipated to increase from $2.44 billion in 2025 to $2.87 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.8%. The expansion during the past period is a result of breakthroughs in sequencing technologies, a greater occurrence of infectious diseases, the development of microbiome research initiatives, an escalating need for culture-independent diagnostics, and the provision of clinical-grade sequencing workflows.

The metagenomics in healthcare market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $5.46 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.5%. This anticipated growth during the forecast period can be primarily attributed to several factors: the increasing use of precision diagnostics for infectious diseases, greater investments in therapies based on the microbiome, the expansion of genomic epidemiology programs, the growing incorporation of AI into microbial analysis, and a heightened emphasis on personalized treatment approaches. Key trends characterizing this period encompass the wider adoption of metagenomic diagnostics within clinical environments, an increasing reliance on microbiome-based disease profiling, the growing integration of NGS in managing infections, expanded research into personalized microbial therapeutics, and a strengthened focus on quickly identifying pathogens.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28267&type=smp

Which Drivers Are Impacting Market Performance In The Metagenomics In Healthcare Market?

The growing occurrence of infectious diseases is projected to drive the expansion of the metagenomics in healthcare market moving forward. Infectious diseases are defined as illnesses caused by detrimental microorganisms such as bacteria, viruses, fungi, or parasites that can be transmitted directly or indirectly between individuals. The rise in these diseases is attributed to increased travel, which aids in the rapid spread of pathogens across borders. Metagenomics in healthcare assists in combating infectious diseases by enabling the quick and accurate identification of pathogens, making it essential for managing infectious outbreaks. It helps reduce diagnostic uncertainty by analyzing complex microbial communities, leading to improved patient outcomes and guiding targeted treatments. For instance, in February 2024, the UK Health Security Agency, a UK-based government agency, reported that tuberculosis cases in England escalated to 4,850 in 2023, representing a 10.7% increase from 4,380 cases in 2022. Thus, the increasing prevalence of infectious diseases is a significant driver for the growth of the metagenomics in healthcare market.

Which Segments Are Contributing To The Growth Of The Metagenomics In Healthcare Market?

The metagenomics in healthcare market covered in this report is segmented –

1) By Types: Sample Extraction Kits, Metagenomics Kits

2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray

3) By Workflow: Sample Collection, Deoxyribonucleic Acid Extraction, Library Preparation, Sequencing

4) By Application: Infectious Disease Diagnosis, Genomic Epidemiology, Personalized Medicine, Microbiome Analysis, Drug Discovery

5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Biotechnology Companies

Subsegments:

1) By Sample Extraction Kits: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Protein Extraction Kits

2) By Metagenomics Kits: Library Preparation Kits, Sequencing Kits, Target Enrichment Kits

Which Trends Are Guiding The Evolution Of The Metagenomics In Healthcare Market?

Leading firms in the metagenomics in healthcare market are concentrating on creating inventive solutions, notably microbial community profiling, to improve disease diagnosis, facilitate tailored treatments, and propel precision medicine forward. Microbial community profiling entails the thorough examination and description of varied microbial populations within a particular setting or specimen, employing sequencing and bioinformatics tools to pinpoint their composition, diversity, and functional capacities. For instance, in August 2024, MGI Tech Co. Ltd., a China-based biotechnology company, unveiled a Human Microbiome Metagenomics Sequencing Package designed to further microbial research and healthcare uses. This offering provides an automated, comprehensive workflow for microbial community profiling, enabling the efficient analysis of human microbiome diversity, function, and disease connections through validated high-throughput platforms. It reduces manual effort, boosts reproducibility, and lowers expenses, thereby making large-scale and clinical microbiome research more attainable. Researchers benefit from swift and accurate microbial identification, coupled with flexible throughput, which assists in biomarker discovery and advances translational health studies.

Who Are The Top-Performing Companies In The Metagenomics In Healthcare Market In Recent Years?

Major companies operating in the metagenomics in healthcare market are F. Hoffmann-La Roche AG, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Corporation, Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., MedGenome Labs Limited, Zymo Research Corporation, BaseClear B.V., Psomagen Inc., Karius Inc., Microsynth AG, Macrogen Inc., Norgen Biotek Corp., Tiny Health Inc., CosmosID Inc., Kanvas Biosciences Inc., Phase Genomics Inc., Wobble Genomics Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/metagenomics-in-healthcare-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Metagenomics In Healthcare Market?

North America was the largest region in the metagenomics in healthcare market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metagenomics in healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Metagenomics In Healthcare Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28267&type=smp

Browse Through More Reports Similar to the Global Metagenomics In Healthcare Market 2026, By The Business Research Company

Genomics In Cancer Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

Metagenomic Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report

Metabolomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795